-
New Modalities
Investigating how oligonucleotide-based therapies can boost immune response and improve checkpoint i
...
-
Drug Delivery
1. PK/PD Modeling and Simulation: Highlight the importance of pharmacokinetic (PK) and pharmacodynam
...
-
Oligonucleotide Discovery
-
Oligonucleotide Discovery
-
CMC & Process Development
-
CMC & Process Development
Aligning analytical workflows with FDA/EMA requirements, ensuring robust impurity profiling, and val
...
-
Drug Delivery
-
Oligonucleotide Discovery
-
Oligonucleotide Discovery
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
Afternoon Refreshments
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
1-2-1 Meetings/Networking Break
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
Evening Drinks Reception
-
New Modalities
-
CMC & Process Development
-
CMC & Process Development
-
Oligonucleotide Discovery
-
Oligonucleotide Discovery
Oligonucleotide therapeutics purification relies heavily on preparative-scale chromatography. Revers
...
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
1-2-1 Meetings/Networking Break
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
Networking Lunch
-
Drug Delivery
-
New Modalities
Exploring new platforms such as DNAzymes, aptamers, and circular RNAs for enhanced stability and fun
...
-
CMC & Process Development
-
CMC & Process Development
Optimizing process characterization and scalability by addressing purification, yield, and consiste
...
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
Morning Refreshments
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
1-2-1 Meetings/Networking Break
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
1-2-1 Meetings/Networking Break
-
Oligonucleotide Discovery
-
Oligonucleotide Discovery
-
-
Oligonucleotide Discovery
-
Drug Delivery
-
CMC & Process Development
-
New Modalities
Registration
-
New Modalities
Lessons from approved oligonucleotide therapies (e.g., for SMA and DMD) and their potential in cardi
...
-
Drug Delivery
-
CMC & Process Development
-
CMC & Process Development
Navigating evolving requirements in the US and Europe, including release testing, characterization,
...
)
)
)
)
)
)
)
)